LED to be honest the most substantial news that will affect the company in a big way is the approval for Ryoncil as that will make us reassured that FDA has positive sentiment regarding the product. Everything else in the meantime wont be really substantial. I know some CEOs are more involved in sharing the smallest of progress the company is making but I think Silviu isnt one of them. Lets just hope we get our first approval and then many avenues will open for MSB. Good luck.
Presentation on ASX Gems Conference on 21st June, page-185
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 97.0¢ | $2.821M | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24920 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 35000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |